Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8903 |
High Similarity |
NPD3817 |
Phase 2 |
0.8684 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD5494 |
Approved |
0.8599 |
High Similarity |
NPD7819 |
Suspended |
0.8599 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8599 |
High Similarity |
NPD2801 |
Approved |
0.8535 |
High Similarity |
NPD1934 |
Approved |
0.8509 |
High Similarity |
NPD1247 |
Approved |
0.8506 |
High Similarity |
NPD1512 |
Approved |
0.85 |
High Similarity |
NPD919 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8481 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.84 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8377 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8354 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8302 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8166 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8095 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8086 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8036 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7935 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7764 |
Intermediate Similarity |
NPD920 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD5401 |
Approved |
0.775 |
Intermediate Similarity |
NPD2534 |
Approved |
0.775 |
Intermediate Similarity |
NPD2532 |
Approved |
0.775 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7722 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7712 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2800 |
Approved |
0.764 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7602 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7556 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7532 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7529 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7444 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD37 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7372 |
Intermediate Similarity |
NPD943 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD447 |
Suspended |
0.731 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7167 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8312 |
Approved |
0.716 |
Intermediate Similarity |
NPD6386 |
Approved |
0.716 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD17 |
Approved |
0.707 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7066 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7005 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7 |
Intermediate Similarity |
NPD6781 |
Approved |
0.6994 |
Remote Similarity |
NPD2353 |
Approved |
0.6994 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD4585 |
Approved |
0.697 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1876 |
Approved |
0.6962 |
Remote Similarity |
NPD7095 |
Approved |
0.6961 |
Remote Similarity |
NPD7240 |
Approved |
0.6959 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD1608 |
Approved |
0.6948 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6941 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD7874 |
Approved |
0.6939 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6937 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6936 |
Remote Similarity |
NPD5978 |
Approved |
0.6936 |
Remote Similarity |
NPD5977 |
Approved |
0.6933 |
Remote Similarity |
NPD2438 |
Suspended |
0.6928 |
Remote Similarity |
NPD2309 |
Approved |
0.6928 |
Remote Similarity |
NPD6190 |
Approved |
0.6927 |
Remote Similarity |
NPD5005 |
Approved |
0.6927 |
Remote Similarity |
NPD5006 |
Approved |
0.6923 |
Remote Similarity |
NPD2797 |
Approved |
0.6923 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6918
|
Remote Similarity |
NPD1296 |
Phase 2 |